Partitioning of alveolar and conducting airway nitric oxide in scleroderma lung disease

American Journal of Respiratory and Critical Care Medicine

Volumn 165, Issue 12, 2002, Pages 1587-1591

  Girgis, Reda E ^a,b,c,d   Gugnani, Manish K ^a,b,c,d   Abrams, Judith ^a,b,c,d   Mayes, Maureen D ^a,b,c,d  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Division of Pulmonary Critical Care and Sleep Medicine   (United States)

^c Division of Rheumatology   (United States)

^d WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Interstitial lung disease; Nitric oxide; Pulmonary hypertension; Scleroderma

Indexed keywords

NITRIC OXIDE;

ADULT; AIRWAY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG ALVEOLUS; LUNG DISEASE; LUNG FUNCTION TEST; MALE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SCLERODERMA;

FEMALE; HUMANS; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; NITRIC OXIDE; PREDICTIVE VALUE OF TESTS; PULMONARY ALVEOLI; RESPIRATORY FUNCTION TESTS; SCLERODERMA, SYSTEMIC; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0037098037     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/rccm.2104003     Document Type: Article

References (47)

1. Organ involvement, pulmonary
2. Pathogenesis, fusion
3. Structural features of interstitial lung disease in systemic sclerosis
4. Pathogenesis and evolution of plexiform lesions in pulmonary hypertension associated with scleroderma and human immunodeficiency virus infection
5. The L-arginine-nitric oxide pathway
6. Pathophysiology of nitric oxide and related species: Free radical reactions and modification of biomolecules
7. Role of nitric oxide in autoimmunity
8. Increased nitric oxide production in patients with systemic sclerosis
9. Correlation between increased nitric oxide production and markers of endothelial activation in systemic sclerosis: Findings with the soluble adhesion molecules E-selectin, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1
10. Nitric oxide production and inducible nitric oxide synthase expression in systemic sclerosis
11. Increased production of nitric oxide stimulated by interleukin-1β in peripheral blood mononuclear cells in patients with systemic sclerosis
12. Increased production of the potent oxidant peroxynitrite in the lungs of patients with idiopathic pulmonary fibrosis
13. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension
14. Recommendations for standardized procedures for the on-line and off-line measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children - 1999
15. Decreased nitric oxide in the exhaled air of patients with systemic sclerosis with pulmonary hypertension
16. Increased nitric oxide in exhaled air in patients with systemic sclerosis
17. Exhaled nitric oxide is increased in active fibrosing alveolitis
18. Exhaled nitric oxide in systemic sclerosis: Relationships with lung involvement and pulmonary hypertension
19. 2 in humans: Effect of dynamically changing flow rate
20. A two-compartment model of pulmonary nitric oxide exchange dynamics
21. Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis
22. High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: Analysis of a two-year, double-blind, randomized, controlled clinical trial
23. Primary pulmonary hypertension
24. Recommended standardized procedures for pulmonary testing
25. Standardization of spirometry - 1987 update
26. Single breath carbon monoxide diffusing capacity (transfer factor): Recommendations for a standard technique - 1995 Update
27. Lung volumes in healthy nonsmoking adults
28. Single breath diffusing capacity in a representative sample of the population of Michigan, a large industrial state. Predicted values, lower limits of normal, and frequencies of abnormality by smoking history
29. High resolution computed tomography as a predictor of lung histology in systemic sclerosis
30. Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis
31. Airway nitric oxide diffusion in asthma: Role in pulmonary function and bronchial responsiveness
32. Extended exhaled NO measurement differentiates between alveolar and bronchial inflammation
33. Exhaled nitric oxide is elevated in patients with progressive systemic sclerosis without interstitial lung disease
34. Pulmonary function in scleroderma
35. The pulmonary pathologic manifestations of the CREST syndrome
36. Monocytes of patients with systemic sclerosis (scleroderma) spontaneously release in vitro increased amounts of superoxide anion
37. Chemiluminescent measurements of nitric oxide pulmonary diffusing capacity and alveolar production in humans
38. A simultaneous single breath measurement of pulmonary diffusing capacity with nitric oxide and carbon monoxide
39. Determination of lung capillary blood volume and membrane diffusing capacity in patients with COLD using the NO-CO method
40. Early diagnosis of chronic pulmonary vascular obstruction. Value of pulmonary function tests
41. Physiology of interstitial lung disease
42. Pulmonary diffusing capacities for nitric oxide and carbon monoxide determined by rebreathing in dogs
43. Endothelial expression of nitric oxide synthases and nitrotyrosine in systemic sclerosis skin
44. Interactions of oxidant stress and vascular reactivity
45. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension
46. Exhaled nitric oxide does not provide a marker of vascular endothelial function in healthy humans
47. Cyclophosphamide is associated with pulmonary function and survival benefit in patients with scleroderma and alveolitis